Failed Back Surgery Syndrome and intrathecal drugs infusion

European Journal of Pain Supplements

Volumn 4, Issue 4, 2010, Pages 299-301

  Demartini, Laura ^a   Stocco, Elisa ^a   Bonezzi, Cesare ^a  

^a IRCCS   (Italy)

Author keywords

Failed Back Surgery Syndrome; Intrathecal drugs infusion; Intrathecal opioids; Low back and leg pain; Ziconotide

Indexed keywords

BACLOFEN; BUPIVACAINE; CLONIDINE; DIAMORPHINE; HYDROMORPHONE; MIDAZOLAM; MORPHINE; OMEGA CONOTOXIN MVIIA; OPIATE;

AMENORRHEA; ANALGESIA; ARTICLE; BACKACHE; CHRONIC PAIN; CLINICAL PRACTICE; DRUG DELIVERY SYSTEM; DRUG INFUSION; DRUG SUBSTITUTION; FAILED BACK SURGERY SYNDROME; FOOT EDEMA; GRANULOMA; HUMAN; HYPOGONADISM; LEG PAIN; LOW BACK PAIN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SIDE EFFECT; SPINAL CORD STIMULATION; SPINE SURGERY; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 78149357017     PISSN: 17543207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eujps.2010.09.015     Document Type: Article

References (19)

1. Yousef AA, El-Deen AS, Al-Deeb AE. The role of adding hyaluronidase to fluoroscopically guided caudal steroid and hypertonic saline injection in patients with failed back surgery syndrome: a prospective, double-blinded, randomized study. Pain Pract 2010 April 19 [Epub ahead of print].
2. Deer T., Krames E.S., Hassenbusch S.J., et al. Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 2007, 10(4):300-328.
3. Hassenbusch S.J., Portenoy R.K., Cousins M., et al. Polyanalgesic consensus conference: an update on the management of pain by intraspinal drug delivery - report of an expert panel. J Pain Symptom Manage 2004, 27:540-563.
4. Krames E.S. Practical issues when using neuraxial infusion. Oncology (Willinston Park) 1999, 13(5 Suppl. 2):37-44.
5. Peng P.W., Fedoroff I., Jacques L., Kumar K. Survey of the practice of spinal cord stimulators and intrathecal analgesic delivery implants for management of pain in Canada. Pain Res Manage 2007, 12(4):281-285.
6. Osenbach R.K., Harvey S. Neuraxial infusion in patients with chronic intractable cancer and noncancer pain. Curr Pain Headache Rep 2001, 5(3):241-249.
7. Rainov N.G., Heidecke V., Burkert W. Long-term intrathecal infusion of drugs combinations for chronic back and leg pain. J Pain Symptom Manage 2001, 22(4):862-871.
8. Deer T.R., Caraway D.L., Kim C.K., Dempsey C.D., Stewart C.D., McNeil K.F. Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine. Spine J 2002, 2(4):274-278.
9. Raphael J.H., Southall J.L., Granadurai T.V., Trehame G.J., Kitas G.D. Long-term experience with intrathecal drug administration systems for failed back syndrome and chronic mechanical low back pain. BMC Muscoloskelet Disord 2002, 20:3-17.
10. Kumar K., Hunter G., Demeria D.D. Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis. J Neurosurg 2002, 97(4):803-810.
11. Deer T., Chapple I., Classen A., Javery K., Stoker V., Tonder L., et al. Intrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for low back pain. Pain Med 2004, 5:6-13.
12. Abs R., Verhelst J., Maeyaert J., Van Buyten J.P., Opsomer F., Adriaensen H., et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000, 85(6):2215-2222.
13. Aldrete J.A., Couto da Silva J.M. Leg edema from intrathecal opiate infusions. Eur J Pain 2000, 4(4):361-365.
14. Scherens A., Kagel T., Zenz M., Maier C. Long-term respiratory depression induced by intrathecal morphine treatment for chronic neuropathic pain. Anesthesiology 2006, 105:14-25.
15. Johansen M.J., Satterfield W.C., Baze W.B., Hildebrand K.R., Gradert T.L., Hassenbusch S.J. Continuous intrathecal infusion of hydromorphone: safety in the sheep model and clinical implications. Pain Med 2004, 5(1):14.
16. Coffey R.J., Burkiel K. Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients. Neurosurgery 2002, 50(1):78-86.
17. Deer T.R., Krames E., Levy R.M., Hassenbusch S.J., Prager S.P. Practice choices and challenges in the current intrathecal therapy environment: an online survey. Pain Med 2009, 10(2):304-309.
18. Rauck R.L., Wallace M.S., Leong M.S., Minehart M., Webster L.R., Charapata S.G., et al. Ziconotide 301 Study Group. A randomized, doubleblind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 2006, 31:393-406.
19. Manchikanti L., Boswell M.V., Singh V., Benyamin R.M., Fellows B., Abdi S., et al. ASIPP-IPM. Comprehensive evidence based guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician 2009, 12(4):699-802.